肝星状细胞
基因敲除
微泡
细胞生物学
化学
纤维化
癌症研究
小RNA
过氧化物酶体增殖物激活受体
生物
内科学
内分泌学
医学
受体
生物化学
细胞凋亡
基因
作者
Qiang Wang,Hao Wang,Qingxu Jing,Yang Yang,Dongbo Xue,Chen jun Hao,Weihui Zhang
标识
DOI:10.1101/2020.12.01.407585
摘要
ABSTRACT As endogenous miRNA carriers,exosomes play a role in the pathophysiological process of various diseases. However, their functions and regulation mechanisms in pancreatic fibrosis remain unclear. In this study, an RNA microarray was used to detect differentially expressed exosomal miR-130a-3p in AR42J cells after taurolithocholate (TLC) treatment. mRNA-seq was used to screen the differentially expressed PPAR-γ after pancreatic stellate cell (PSC) activation. Fluorescence labeling of exosomes and dynamic tracing showed that exosomes can fuse with the cell membrane of PSCs and transport miR-130a-3p into PSCs. A luciferase reporter gene assay was used to confirm that miR-130a can bind to PPAR-γ to inhibit PPAR-γ expression. In vitro and in vivo functional experiments were performed for gain-of-function studies and loss-of-function studies, respectively. These studies showed that acinar cell-derived exosomal miR-130a-3p promotes PSC activation and collagen formation through targeting of cellular PPAR-γ. Knockdown of miR-130a-3p significantly improved pancreatic fibrosis. Notably, miR-130a-3p knockdown reduced serum levels of hyaluronic acid (HA) and β-amylase and increased the C-peptide to protect endocrine and exocrine pancreatic functions and the function of endothelial cells. The exosomal miR-130a-3p/PPAR-γ axis participates in the activation of PSCs and the mechanism of CP fibrosis, thus providing a potential new target for the treatment of chronic pancreatitis fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI